Retrospective Cohort Study on the Impact of the COVID-19 Pandemic on Pregnancy Outcomes for Women Living With HIV in British Columbia
- PMID: 38489490
- DOI: 10.1097/QAI.0000000000003384
Retrospective Cohort Study on the Impact of the COVID-19 Pandemic on Pregnancy Outcomes for Women Living With HIV in British Columbia
Abstract
Background: For pregnant women living with HIV (WLWH), engagement in care is crucial to maternal health and reducing the risk of perinatal transmission. To date, there have been no studies in Canada examining the impact of the COVID-19 pandemic on pregnant WLWH.
Methods: This was a retrospective cohort study assessing the impact of the pandemic on perinatal outcomes for pregnant WLWH using data from the Perinatal HIV Surveillance Program in British Columbia, Canada. We compared maternal characteristics, pregnancy outcomes, and clinical indicators related to engagement with care between a prepandemic (January 2017-March 2020) and pandemic cohort (March 2020-December 2022). We investigated preterm birth rates with explanatory variables using logistic regression analysis.
Results: The prepandemic cohort (n = 87) had a significantly (P < 0.05) lower gestational age at the first antenatal encounter (9.0 vs 11.8) and lower rates of preterm births compared with the pandemic cohort (n = 56; 15% vs 37%). Adjusted odds of preterm birth increased with the presence of substance use in pregnancy (aOR = 10.45, 95% confidence interval: 2.19 to 49.94) in WLWH. There were 2 cases of perinatal transmission of HIV in the pandemic cohort, whereas the prepandemic cohort had none.
Conclusions: The pandemic had pronounced effects on pregnant WLWH and their infants in British Columbia including higher rates of preterm birth and higher gestational age at the first antenatal encounter. The nonstatistically significant increase in perinatal transmission rates is of high clinical importance.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
E.M. receives salary support in the form of postdoctoral fellowships from the Canadian HIV Trials Network/CANFAR and Michael Smith Health Research BC. A.A. is supported by the RANZCOG Jean Murray-Jones Scholarship. C.E. has served as an advisory board member for Gilead, as a reproductive infectious disease specialist. L.S. has research funding from the Public Health Agency of Canada and Women's Health Research Institute (Vancouver, Canada). T.S. has had contact in consultative capacity with ViiV and Gilead Sciences. For the remaining authors, no conflicts of interest were declared.
References
-
- Dudevich A, Frood J. Impact of the COVID-19 pandemic on health system use in Canada. Healthc Q. 2021;24:12–14.
-
- Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11:e045343.
-
- Kronfli N, Lacombe-Duncan A, Wang Y, et al. Access and engagement in HIV care among a national cohort of women living with HIV in Canada. AIDS Care. 2017;29:1235–1242.
-
- Erickson M, Shannon K, Sernick A, et al. Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories. AIDS. 2019;33:101–111.
-
- Ion A, Greene S, Mellor K, et al. Perinatal care experiences of mothers living with HIV in Ontario, Canada. J HIV/AIDS Social Serv. 2016;15:180–201.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical